肠源性高草酸尿症的发病机制与治疗进展  

Progress in Pathogenesis and Treatment of Enteric Hyperoxaluria

作　　者：杨顺航 李炯明[1] 刘建和[1] 王光[1] 李沛[1] YANG Shunhang;LI Jiongming;LIU Jianhe;WANG Guang;LI Pei(Dept,of Urology,The 2nd Affiliated Hospital of Kunming Medical University,Kunming Yunnan 650032,China)

机构地区：[1]昆明医科大学第二附属医院泌尿外科三病区,云南昆明650032

出　　处：《昆明医科大学学报》2022年第7期152-155,共4页Journal of Kunming Medical University

基　　金：国家自然科学基金资助项目(82060137)。

摘　　要：肠源性高草酸尿症是由多种原因引起的以肠道草酸盐过量吸收和尿草酸盐排泄增加为特点的继发性高草酸尿症。肠源性高草酸尿症与尿路草酸钙结石的发生密切相关,有效减少肠道草酸盐的吸收,降低尿草酸盐的排泄,对预防尿路草酸钙结石的发生具有重要意义。回顾了近年来有关肠源性高草酸尿症的发病机制与治疗方面的相关文献,综述如下。Enteric hyperoxaluria is a secondary hyperoxaluria characterized by excessive absorption of intestinal oxalate and increased urinary oxalate.Enteric hyperoxaluria is closely related to the occurrence of urinary calcium oxalate stones.It is of great significance to effectively reduce the absorption of intestinal oxalate and urinary oxalate to prevent the occurrence of urinary calcium oxalate stones.This article reviews the pathogenesis and treatment of enteric hyperoxaluria.

关 键 词：肠源性高草酸尿症 继发性高草酸尿症 草酸钙结石 尿草酸盐 肠道菌群 

分 类 号：R692.4[医药卫生—泌尿科学]